An Alcohol Cross-Tolerance Experiment Used WIN 55,212-2, Not THC

Repeated alcohol exposure reduced selected responses to a synthetic cannabinoid in mice. That result cannot be restated as proof that people who drink heavily are protected from marijuana’s effects.

The tested cannabinoid matters

Male mice received ethanol twice daily for ten days before a challenge with WIN 55,212-2. WIN is an experimental cannabinoid-receptor agonist, not delta-9 THC or whole-plant cannabis. The study assessed locomotion, responses to painful heat, body temperature and catalepsy.

Three outcomes changed; one did not

Prior ethanol reduced WIN-related suppression of movement, antinociception and hypothermia. Catalepsy did not show the same significant change. After a further ten-day recovery period, the measured sensitivity differences were no longer significant. These findings describe selected behavioral responses and a particular observation window.

Brain results were regional

The investigators measured CB1 protein in dissected brain regions. Changes differed by region rather than showing a uniform whole-brain decrease. These tissue measurements were not blood THC concentrations and did not provide an individual impairment threshold.

Cross-tolerance has a direction

The experiment tested ethanol history followed by a cannabinoid challenge. It did not establish the reverse relationship or test simultaneous alcohol–THC exposure in drivers. Species, injected dosing, agonist efficacy and the specific tasks restrict translation. A sound opinion names both drugs, the direction of exposure and the endpoint instead of using cross-tolerance as a blanket assurance of preserved function.

Related analysis: the separate human alcohol–cannabis attention experiment.

Primary research

Pava MJ; Blake EM; Green ST; Mizroch BJ; Mulholland PJ; Woodward JJ. Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol. Psychopharmacology (2012). DOI: 10.1007/s00213-011-2387-0.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

How Did a Laboratory Study Decide That a Detected Drug Was Non-Prescribed?

A laboratory can identify a drug while relying on outside information to classify its prescription status. A national urine-testing study combined analytical results with medication information supplied by the ordering clinician. Two information streams McClure and colleagues analyzed 231,228 test-result sets from 144,535 patients tested for both opioids and benzodiazepines….

Spread the love

Read Article: How Did a Laboratory Study Decide That a Detected Drug Was Non-Prescribed?

How Did a Stress-Management Trial Protocol Handle Medication Changes?

When a study evaluates psychological treatment, medication changes can complicate attribution of improvement. The 2017 Seren@ctif protocol described how investigators planned to address this issue in a trial of adjustment disorder with anxiety. The planned comparison Servant and colleagues proposed three randomized groups receiving computer-based stress management, an equivalent face-to-face…

Spread the love

Read Article: How Did a Stress-Management Trial Protocol Handle Medication Changes?

What Evidence Supports Extending Lipid Rescue to a Different Poison?

A treatment that appears useful for one toxicant raises a separate scientific question when proposed for another. Eisenkraft and Falk’s 2016 review of lipid emulsion and chemical-agent poisoning provides an example of that evidence gap. Several evidence types The authors discussed proposed lipid-scavenging, metabolic, and cardiovascular mechanisms. They reviewed laboratory…

Spread the love

Read Article: What Evidence Supports Extending Lipid Rescue to a Different Poison?

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us